08:29 AM EDT, 09/08/2025 (MT Newswires) -- Dianthus Therapeutics ( DNTH ) said Monday claseprubart demonstrated statistically significant and clinically meaningful improvements in a phase 2 study of adults with acetylcholine receptor antibody positive generalized myasthenia gravis. The therapy improved daily living and muscle strength scores as early as the first week and maintained benefits through week 13, the company...

08:26 AM EDT, 09/08/2025 (MT Newswires) -- Netskope expects to raise between $717 million and $812.6 million in its initial public offering, according to a Monday filing with the US Securities and Exchange Commission. The cloud-security provider said it will offer 47.8 million class A common shares, expected to be priced between $15 and $17 per share. Underwriters have been...

08:28 AM EDT, 09/08/2025 (MT Newswires) -- Oncolytics Biotech ( ONCY ) said Monday that data from three metastatic colorectal cancer, or mCRC studies for its immunotherapy pelareorep showed consistent efficacy signals, immune activation, and survival outcomes that exceeded benchmarks in multiple treatment settings. The REO 022 trial, which evaluates pelareorep in combination with Folfiri and bevacizumab in platinum refractory...

08:28 AM EDT, 09/08/2025 (MT Newswires) -- Marqeta ( MQ ) said Monday it has appointed Mike Milotich as chief executive officer, effective today. The company said Milotich has served as interim CEO since February, in addition to his role of chief financial officer. He will continue to serve as CFO until a successor has been identified, the company said....